Category Medicine and Healthcare

DEA Marijuana Hypocrisy On Full Display: Why are U.S. Cannabis Companies Exporting Illegally While MMJ BioPharma Is Stonewalled?
Press Release

DEA Marijuana Hypocrisy On Full Display: Why are U.S. Cannabis Companies Exporting Illegally While MMJ BioPharma Is Stonewalled?

"The Drug Enforcement Administration (DEA) is embroiled in a glaring contradiction: While federally compliant medical cannabis researchers like MMJ BioPharma Cultivation remain paralyzed by bureaucratic delays, U.S. recreational cannabis companies are openly exporting products, intellectual property and money to Europe-flouting federal law with no DEA intervention", stated Duane Boise, CEO MMJ. This double standard exposes a system prioritizing corporate profits over scientific progress and public health, undermining the DEA's mandate under the Controlled Substances Act (CSA).

Read More
DEA Defies Supreme Court and Attorney General, Targeting Marijuana Compliant Pharmaceutical Research While Cartels Operate Unchecked
Press Release

DEA Defies Supreme Court and Attorney General, Targeting Marijuana Compliant Pharmaceutical Research While Cartels Operate Unchecked

"The irony is glaring," said Boise. "The DEA blocks lawful drug development while cartels profit. The agency is both gatekeeper and roadblock-and now, a constitutional liability." The DEA's own 2025 National Drug Threat Assessment admits that illicit cannabis operations tied to foreign cartels thrive in legalized states, operating under state licenses while DEA policy bureaucrats Thomas Prevoznik and Matthew Strait remains unchecked.

Read More